Recombinant human insulin-like growth factor-I in ALS: Description of a double-blind, placebo-controlled study

Neurology

Volumn 47, Issue 4 SUPPL., 1996, Pages

  Lange, D J ^b   Felice, K J ^c   Festoff, B W ^d   Gawel, M J ^j   Gelinas, D F ^e   Kratz, R ^f   Lai, E C ^a   Murphy, M F ^g   Natter, H M ^h   Norris, F H ^e   Rudnicki, S ⁱ  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^f GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^g CEPHALON INC   (United States)

^h HAHNEMANN UNIVERSITY HOSPITAL   (United States)

ⁱ UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^j UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT SOMATOMEDIN C;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MUSCLE STRENGTH; NORTH AMERICA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 10244237798     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.47.4_suppl_2.93s     Document Type: Article

References (1)

1. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987;22:328-333.